Researchers have revealed 40 genes involved in the development of myeloma, increasing our understanding of the complex genetics behind the incurable blood cancer.
The Myeloma UK Garden by RHS Gold medal winning designers John Everiss and Francesca Murrell will breathe life into the RHS Chelsea Flower Show 2018 and is one of three major events that will mark the blood cancer charity’s 21 years of making myeloma history.
Myeloma patients in England and Wales will now be able to access the new myeloma treatment, ixazomib (Ninlaro ®) on […]
10 October 2017 – Myeloma UK has launched MUK nine, the first UK-wide molecularly stratified myeloma trial.
Patients in Scotland will now be able to access the new myeloma treatment, daratumumab (Darzalex®) on the NHS, after the Scottish Medicines Consortium (SMC) approved it for use.
The National Institute for Health and Care Excellence (NICE) has issued a second draft “no” on ixazomib (Ninlaro®) for the […]
From today, myeloma patients in Scotland will be able to access new myeloma treatment, carfilzomib (Kyprolis®) on the NHS, after […]
An experienced and accomplished healthcare leader has been appointed Chief Executive of Myeloma UK. Rosemarie Finley is joining Myeloma UK […]
The National Institute for Health and Care Excellence (NICE) has approved carfilzomib (Kyprolis®) in combination with dexamethasone for use on […]
Alcentra CEO and philanthropist David Forbes-Nixon has donated £1 million over 5 years to Myeloma UK through the DFN Charitable […]